Lamark Biotech’s Bold Bet on Thermostable Insulin Could Transform Diabetes Care in India and Beyond
In a major win for healthcare innovation in India, Lamark Biotech, an Ahmedabad-based biopharma startup, has raised Rs 6.5 crore in a pre-Series A funding round led by IAN Group, including IAN Alpha Fund powered by BioAngels, and a group of top angel investors with deep expertise in…
Bengaluru-Based Lamark Biotech Raises Rs 6.5 Crore to Transform Biologic Therapies
In a breakthrough moment for India’s biotech ecosystem, Lamark Biotech has secured Rs 6.5 crore in its pre-Series A funding round. The round, led by IAN Group—through funds like IAN Alpha and BioAngels—also saw participation from notable angel investors, including Dr. Vinayender Tulla, Dr. Nita Roy, and…
